fluxd.news

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline · fluxd.news

LIVE

Fintech

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

Cnbc·March 25, 2026 at 11:14 AM

Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.

Original Source

Cnbc — www.cnbc.com

Related in Fintech

EU Auditor Seeks Reforms for Cross-Border Services
PYMNTS
Stablecoin Regulations Focus on Wallets for Adoption
PYMNTS
Crypto market structure bill faces fractured industry reaction
CoinDesk
Platforms Restrict AI Agent Access
PYMNTS